Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …

Objective To describe the growing importance of enthesitis in patients with psoriatic arthritis (PsA)
and discuss the advantages and disadvantages of clinical and imaging methods …

Objective Dactylitis—long considered a hallmark clinical feature of psoriatic arthritis (PsA)—occurs
in 16–49% of patients with PsA. In this review, we discuss the pathology of dactylitis …

Objective To estimate the incidence of psoriatic arthritis (PsA) in patients with psoriasis, and
to identify risk factors for its development. Methods The study was designed as a prospective …

Objective To determine whether the presence of psoriatic arthritis (PsA) is associated with
greater comorbidity, in particular cardiovascular morbidity, compared to psoriasis without …

Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA)
clinical trials that represent both patients' and physicians' priorities. Methods We …

Objective. (1) To determine the prevalence of depression and anxiety in patients with psoriatic
arthritis (PsA) and to identify associated demographic and disease-related factors. (2) To …

Objective To assess the magnitude of risk of cardiovascular and cerebrovascular morbidity
in patients with psoriatic arthritis (PsA) compared with the general population through a …

Objective. PsA is an inflammatory arthritis present in ∼30% of people with psoriasis (PsC).
Both conditions have a significant impact on quality of life (QoL). Our objective was to test the …

Aim To assess whether overweight and obese patients with psoriatic arthritis (PsA) are less
likely to achieve sustained minimal disease activity (MDA) state compared to patients with …